JP2005528086A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005528086A5 JP2005528086A5 JP2003556443A JP2003556443A JP2005528086A5 JP 2005528086 A5 JP2005528086 A5 JP 2005528086A5 JP 2003556443 A JP2003556443 A JP 2003556443A JP 2003556443 A JP2003556443 A JP 2003556443A JP 2005528086 A5 JP2005528086 A5 JP 2005528086A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- nucleic acid
- polypeptide
- acid molecule
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920001184 polypeptide Polymers 0.000 claims 26
- 108090000765 processed proteins & peptides Proteins 0.000 claims 26
- 102000004196 processed proteins & peptides Human genes 0.000 claims 26
- 150000007523 nucleic acids Chemical class 0.000 claims 25
- 108020004707 nucleic acids Proteins 0.000 claims 24
- 102000039446 nucleic acids Human genes 0.000 claims 24
- 201000010099 disease Diseases 0.000 claims 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 18
- 238000000034 method Methods 0.000 claims 9
- 239000000523 sample Substances 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 6
- 230000000694 effects Effects 0.000 claims 6
- 208000023275 Autoimmune disease Diseases 0.000 claims 4
- 208000024172 Cardiovascular disease Diseases 0.000 claims 4
- 206010040070 Septic Shock Diseases 0.000 claims 4
- 238000003745 diagnosis Methods 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 208000027866 inflammatory disease Diseases 0.000 claims 4
- 210000001519 tissue Anatomy 0.000 claims 4
- 208000019693 Lung disease Diseases 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 3
- 208000036142 Viral infection Diseases 0.000 claims 3
- 239000013068 control sample Substances 0.000 claims 3
- 230000007823 neuropathy Effects 0.000 claims 3
- 201000001119 neuropathy Diseases 0.000 claims 3
- 208000033808 peripheral neuropathy Diseases 0.000 claims 3
- 230000002062 proliferating effect Effects 0.000 claims 3
- 230000009385 viral infection Effects 0.000 claims 3
- 208000030507 AIDS Diseases 0.000 claims 2
- 208000012124 AIDS-related disease Diseases 0.000 claims 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 208000009137 Behcet syndrome Diseases 0.000 claims 2
- 208000019838 Blood disease Diseases 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 206010010741 Conjunctivitis Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 201000009273 Endometriosis Diseases 0.000 claims 2
- 206010018364 Glomerulonephritis Diseases 0.000 claims 2
- 201000005569 Gout Diseases 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 claims 2
- 208000017604 Hodgkin disease Diseases 0.000 claims 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 2
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 102000014150 Interferons Human genes 0.000 claims 2
- 108010050904 Interferons Proteins 0.000 claims 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 2
- 208000007466 Male Infertility Diseases 0.000 claims 2
- 208000000112 Myalgia Diseases 0.000 claims 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 206010033645 Pancreatitis Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 206010063837 Reperfusion injury Diseases 0.000 claims 2
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 2
- 206010039491 Sarcoma Diseases 0.000 claims 2
- 206010040047 Sepsis Diseases 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 206010046851 Uveitis Diseases 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- 208000037883 airway inflammation Diseases 0.000 claims 2
- 230000007815 allergy Effects 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 230000001363 autoimmune Effects 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 238000009739 binding Methods 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 230000009547 development abnormality Effects 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 210000002249 digestive system Anatomy 0.000 claims 2
- 230000003073 embolic effect Effects 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 208000014951 hematologic disease Diseases 0.000 claims 2
- 208000018706 hematopoietic system disease Diseases 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 229940079322 interferon Drugs 0.000 claims 2
- 208000019423 liver disease Diseases 0.000 claims 2
- 201000004792 malaria Diseases 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 230000006371 metabolic abnormality Effects 0.000 claims 2
- 238000012544 monitoring process Methods 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 206010028417 myasthenia gravis Diseases 0.000 claims 2
- 208000031225 myocardial ischemia Diseases 0.000 claims 2
- 230000001613 neoplastic effect Effects 0.000 claims 2
- 239000002853 nucleic acid probe Substances 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 230000001575 pathological effect Effects 0.000 claims 2
- 239000013610 patient sample Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 206010039083 rhinitis Diseases 0.000 claims 2
- 230000036303 septic shock Effects 0.000 claims 2
- 208000017520 skin disease Diseases 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 230000009261 transgenic effect Effects 0.000 claims 2
- 230000029663 wound healing Effects 0.000 claims 2
- 208000031295 Animal disease Diseases 0.000 claims 1
- 208000014767 Myeloproliferative disease Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 208000010399 Wasting Syndrome Diseases 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 210000001185 bone marrow Anatomy 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 208000016253 exhaustion Diseases 0.000 claims 1
- 230000009390 immune abnormality Effects 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0130720.6A GB0130720D0 (en) | 2001-12-21 | 2001-12-21 | Proteins |
| PCT/GB2002/005914 WO2003055913A2 (en) | 2001-12-21 | 2002-12-23 | Secreted protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005528086A JP2005528086A (ja) | 2005-09-22 |
| JP2005528086A5 true JP2005528086A5 (enExample) | 2006-02-16 |
Family
ID=9928221
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003556442A Abandoned JP2005532034A (ja) | 2001-12-21 | 2002-12-23 | 分泌タンパク質 |
| JP2003554728A Abandoned JP2005528083A (ja) | 2001-12-21 | 2002-12-23 | レプチンタンパク質 |
| JP2003556443A Abandoned JP2005528086A (ja) | 2001-12-21 | 2002-12-23 | 分泌タンパク質 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003556442A Abandoned JP2005532034A (ja) | 2001-12-21 | 2002-12-23 | 分泌タンパク質 |
| JP2003554728A Abandoned JP2005528083A (ja) | 2001-12-21 | 2002-12-23 | レプチンタンパク質 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20040106778A1 (enExample) |
| EP (3) | EP1463756A2 (enExample) |
| JP (3) | JP2005532034A (enExample) |
| KR (1) | KR20040086247A (enExample) |
| CN (1) | CN1620467A (enExample) |
| AU (3) | AU2002356317A1 (enExample) |
| BR (1) | BR0215284A (enExample) |
| CA (3) | CA2470594A1 (enExample) |
| EA (1) | EA007813B1 (enExample) |
| GB (1) | GB0130720D0 (enExample) |
| IL (1) | IL162598A0 (enExample) |
| MX (1) | MXPA04006049A (enExample) |
| WO (3) | WO2003055913A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004050702A2 (en) * | 2002-12-04 | 2004-06-17 | Applied Research Systems Ars Holding N.V. | Novel ifngamma-like polypeptides |
| GB0314456D0 (en) * | 2003-06-20 | 2003-07-23 | Ares Trading Sa | Interferon gamma-like protein |
| EP1636262A1 (en) * | 2003-06-20 | 2006-03-22 | Ares Trading S.A. | Interferon gamma-like protein |
| JP4723496B2 (ja) * | 2003-09-08 | 2011-07-13 | メルク セローノ ソシエテ アノニム | 線維症疾患の治療 |
| CN1914223B (zh) * | 2004-02-02 | 2012-02-29 | Ambrx公司 | 经修饰的人类四螺旋束多肽及其用途 |
| BRPI0507159A (pt) * | 2004-02-02 | 2007-06-26 | Ambrx Inc | polipeptìdeos em feixe de quatro hélices humanos modificados e seus usos |
| US20050260155A1 (en) * | 2004-05-18 | 2005-11-24 | Gopala Kovvali | Compositions and methods for treatment of ulcerative colitis |
| US9155778B2 (en) * | 2005-04-04 | 2015-10-13 | Julius-Maxmillians-Universitat Wurzburg | Tripeptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SgIt1 |
| US7943328B1 (en) | 2006-03-03 | 2011-05-17 | Prometheus Laboratories Inc. | Method and system for assisting in diagnosing irritable bowel syndrome |
| US8432899B2 (en) | 2007-02-22 | 2013-04-30 | Aylus Networks, Inc. | Systems and methods for enabling IP signaling in wireless networks |
| US9026117B2 (en) | 2006-05-16 | 2015-05-05 | Aylus Networks, Inc. | Systems and methods for real-time cellular-to-internet video transfer |
| US20080085524A1 (en) * | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| US20100094560A1 (en) * | 2006-08-15 | 2010-04-15 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| RU2010146772A (ru) * | 2008-06-04 | 2012-07-20 | КейСиАй Лайсензинг, Инк. (US) | Обнаружение инфекции при терапии ран пониженным давлением |
| WO2013059778A2 (en) * | 2011-10-20 | 2013-04-25 | California Stem Cell, Inc. | Antigen presenting cancer vaccine with gamma interferon |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6245966B1 (en) * | 1998-07-14 | 2001-06-12 | University Technology Corporation | Adenoviral mediated gene transfer into lymphocytes |
| AU5724700A (en) * | 1999-06-01 | 2000-12-18 | Zymogenetics Inc. | Four-helical bundle protein zsig81 |
| EP1242598A2 (en) * | 1999-12-30 | 2002-09-25 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| DE60139110D1 (de) * | 2000-01-10 | 2009-08-13 | Maxygen Holdings Ltd | G-csf konjugate |
| US20020048763A1 (en) * | 2000-02-04 | 2002-04-25 | Penn Sharron Gaynor | Human genome-derived single exon nucleic acid probes useful for gene expression analysis |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| JP2004522411A (ja) * | 2000-07-31 | 2004-07-29 | ジーン ロジック インコーポレイテッド | 分子毒性学モデリング |
| WO2004094713A2 (en) * | 2003-04-16 | 2004-11-04 | Applied Dna Sciences, Inc. | System and method for marking textiles with nucleic acids |
| GB0314456D0 (en) * | 2003-06-20 | 2003-07-23 | Ares Trading Sa | Interferon gamma-like protein |
-
2001
- 2001-12-21 GB GBGB0130720.6A patent/GB0130720D0/en not_active Ceased
-
2002
- 2002-12-23 WO PCT/GB2002/005914 patent/WO2003055913A2/en not_active Ceased
- 2002-12-23 CN CNA028282752A patent/CN1620467A/zh active Pending
- 2002-12-23 BR BR0215284-3A patent/BR0215284A/pt not_active IP Right Cessation
- 2002-12-23 AU AU2002356317A patent/AU2002356317A1/en not_active Abandoned
- 2002-12-23 AU AU2002353227A patent/AU2002353227A1/en not_active Abandoned
- 2002-12-23 MX MXPA04006049A patent/MXPA04006049A/es unknown
- 2002-12-23 KR KR10-2004-7009758A patent/KR20040086247A/ko not_active Ceased
- 2002-12-23 IL IL16259802A patent/IL162598A0/xx unknown
- 2002-12-23 EP EP02788245A patent/EP1463756A2/en not_active Withdrawn
- 2002-12-23 EA EA200400812A patent/EA007813B1/ru not_active IP Right Cessation
- 2002-12-23 AU AU2002353224A patent/AU2002353224B2/en not_active Expired - Fee Related
- 2002-12-23 CA CA002470594A patent/CA2470594A1/en not_active Abandoned
- 2002-12-23 WO PCT/GB2002/005890 patent/WO2003055912A2/en not_active Ceased
- 2002-12-23 EP EP02788242A patent/EP1468018A2/en not_active Withdrawn
- 2002-12-23 JP JP2003556442A patent/JP2005532034A/ja not_active Abandoned
- 2002-12-23 EP EP02805839A patent/EP1468019A2/en not_active Withdrawn
- 2002-12-23 WO PCT/GB2002/005885 patent/WO2003054012A2/en not_active Ceased
- 2002-12-23 CA CA002470666A patent/CA2470666A1/en not_active Abandoned
- 2002-12-23 JP JP2003554728A patent/JP2005528083A/ja not_active Abandoned
- 2002-12-23 JP JP2003556443A patent/JP2005528086A/ja not_active Abandoned
- 2002-12-23 CA CA002471306A patent/CA2471306A1/en not_active Abandoned
-
2003
- 2003-06-20 US US10/600,790 patent/US20040106778A1/en not_active Abandoned
-
2004
- 2004-06-21 US US10/872,598 patent/US20050106679A1/en not_active Abandoned
- 2004-06-21 US US10/873,332 patent/US20050042731A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005528086A5 (enExample) | ||
| JP2005528083A5 (enExample) | ||
| JP2005532034A5 (enExample) | ||
| EP2080812A1 (en) | Compositions and methods of detecting post-stop peptides | |
| JP2012512389A5 (enExample) | ||
| CN101852804A (zh) | Gdf15蛋白的抗体的新用途 | |
| CN108085387B (zh) | 检测人brca1/2基因突变的特异性捕获探针、试剂盒、测序文库及其构建方法 | |
| WO2018031897A1 (en) | Compositions and methods for analyzing nucleic acids associated with an analyte | |
| CN105803054A (zh) | 试剂盒及其在检测唇腭裂相关基因中的用途 | |
| CN103003694A (zh) | 人巨细胞病毒感染的检测方法 | |
| CN109957027A (zh) | 一组着丝粒蛋白f（cenpf）分片段抗原及其应用 | |
| JP2007006711A5 (enExample) | ||
| JP4615567B2 (ja) | Ｃ型肝炎ウイルス感染に関連する肝疾患の予後の予測 | |
| CN113234134B (zh) | 一种远端关节挛缩综合症致病基因myh3及其用途 | |
| WO2002095065A2 (en) | G-protein coupled receptor arrays | |
| JP2008509659A5 (enExample) | ||
| CN101622361A (zh) | 用于心律不齐的风险管理的遗传标记物 | |
| CN105319376B (zh) | 一种用于检测鼻咽癌的试剂盒及其检测方法 | |
| JP2006516888A5 (enExample) | ||
| JP2006526386A5 (enExample) | ||
| JP2002518014A (ja) | ヒトｂ型肝炎ウイルス突然変異株およびその使用 | |
| CN119775427B (zh) | 一种抗dsDNA抗体或其抗原结合片段及其应用 | |
| US20240401114A1 (en) | High sensitivity and rapid nucleic acid detection | |
| CN110615845B (zh) | 一种兼有IgG结合活性及生物素结合活性的双功能蛋白及其免疫PCR试剂盒 | |
| KR20200004980A (ko) | Ｂｒｃａ 유전자 변이를 검출하기 위한 프로브와 제조 및 검출 방법 |